Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Sales and Divestitures (2017 - 2025)

Chemours (CC) has 9 years of Gains from Sales and Divestitures data on record, last reported at $273000.0 in Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 20.41% year-over-year to $273000.0; the TTM value through Dec 2025 reached $273000.0, down 20.41%, while the annual FY2025 figure was $273000.0, 20.41% down from the prior year.
  • Gains from Sales and Divestitures reached $273000.0 in Q4 2025 per CC's latest filing, down from $343000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $473000.0 in Q4 2022 and bottomed at $188000.0 in Q4 2021.
  • Average Gains from Sales and Divestitures over 5 years is $333600.0, with a median of $343000.0 recorded in 2024.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 151.6% in 2022, then decreased 20.41% in 2025.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $188000.0 in 2021, then soared by 151.6% to $473000.0 in 2022, then dropped by 17.34% to $391000.0 in 2023, then dropped by 12.28% to $343000.0 in 2024, then fell by 20.41% to $273000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $273000.0 in Q4 2025, $343000.0 in Q4 2024, and $391000.0 in Q4 2023.